Unknown

Dataset Information

Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges.


ABSTRACT: Cardiovascular diseases (CVDs), particularly stroke and myocardial infarction (MI) contributed to the leading cause of death annually among the chronic diseases globally. Despite the advancement of technology, the current available treatments mainly served as palliative care but not treating the diseases. However, the discovery of mesenchymal stem cells (MSCs) had gained a consideration to serve as promising strategy in treating CVDs. Recent evidence also showed that MSCs are the strong candidate to be used as stem cell therapy involving cardiovascular regeneration due to its cardiomyogenesis, anti-inflammatory and immunomodulatory properties, antifibrotic effects and neovascularization capacity. Besides, MSCs could be used for cellular cardiomyoplasty with its transdifferentiation of MSCs

SUBMITTER: Seow KS 

PROVIDER: S-EPMC11304428 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature